Sai Life Sciences (NSE:SAILIFE) Operating Margin %: 21.80% (As of Mar. 2026) — 75% Above Median


NSE:SAILIFE Sai Life Sciences Ltd NSE:SAILIFE
18 GF Score
Price ₹1,221.30
! 4 Warning Signs
View Full Analysis

What is Sai Life Sciences Operating Margin %?

Sai Life Sciences NSE:SAILIFE +1.35% 18 Operating Margin % is 21.80% as of Mar. 2026, which is 75% above its 10-year median of 12.44. GuruFocus rates NSE:SAILIFE with a GF Score™ of 18/100. The stock has 4 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, Sai Life Sciences ranks better than 89.71% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. Sai Life Sciences's Operating Income for the three months ended in Mar. 2026 was ₹1,312 Mil. Sai Life Sciences's Revenue for the three months ended in Mar. 2026 was ₹6,021 Mil. Therefore, Sai Life Sciences's Operating Margin % for the quarter that ended in Mar. 2026 was 21.80%.

The historical rank and industry rank for Sai Life Sciences's Operating Margin % or its related term are showing as below:

NSE:SAILIFE' s Operating Margin % Range Over the Past 10 Years
Min: 4.08   Med: 12.44   Max: 21.18
Current: 21.18


NSE:SAILIFE's Operating Margin % is ranked better than
89.71% of 204 companies
in the Medical Diagnostics & Research industry
Industry Median: -3.195 vs NSE:SAILIFE: 21.18

Sai Life Sciences's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Sai Life Sciences's Operating Income for the three months ended in Mar. 2026 was ₹1,312 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was ₹4,643 Mil.


Sai Life Sciences  (NSE:SAILIFE) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Sai Life Sciences Operating Margin % Related Terms


Sai Life Sciences Operating Margin % Historical Data

* Premium members only.

The historical data trend for Sai Life Sciences's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sai Life Sciences Operating Margin % Chart

Sai Life Sciences Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Operating Margin %
4.08 6.42 12.44 15.76 21.18

Sai Life Sciences Quarterly Data
Mar22 Mar23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.72 16.76 19.74 25.84 21.80

NSE:SAILIFE vs TMO, DHR, IDXX: Operating Margin % Comparison

For the Diagnostics & Research subindustry, Sai Life Sciences's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sai Life Sciences Operating Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Sai Life Sciences's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Sai Life Sciences's Operating Margin % falls into.


NSE:SAILIFE
18GF Score
Sai Life Sciences Ltd NSE:SAILIFE
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sai Life Sciences Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Sai Life Sciences's Operating Margin % for the fiscal year that ended in Mar. 2026 is calculated as

Operating Margin %=Operating Income (A: Mar. 2026 ) / Revenue (A: Mar. 2026 )
=4643.04 / 21924.92
=21.18 %

Sai Life Sciences's Operating Margin % for the quarter that ended in Mar. 2026 is calculated as

Operating Margin %=Operating Income (Q: Mar. 2026 ) / Revenue (Q: Mar. 2026 )
=1312.41 / 6021.39
=21.80 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of 21.80% mean?
Sai Life Sciences (NSE:SAILIFE) has a Operating Margin % of 21.80% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Sai Life Sciences and its competitors. This is 75% above median its historical median of 12.44. Over the past decade, Sai Life Sciences' Operating Margin % has ranged from 4.08 to 21.18. According to the industry distribution chart, Sai Life Sciences ranks #21 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 10.3%.
Is Sai Life Sciences' Operating Margin % too high?
Sai Life Sciences' current Operating Margin % of 21.80% is 75% above median its 10-year median of 12.44. Over the past 10 years, this metric has ranged from a low of 4.08 to a high of 21.18. Based on the distribution chart, Sai Life Sciences ranks #21 out of 204 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Sai Life Sciences has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Sai Life Sciences' Operating Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Sai Life Sciences ranks #21 out of 204 companies for Operating Margin %. This places Sai Life Sciences in the top 10% of its industry — outperforming the majority of peers. Historically, Sai Life Sciences' own Operating Margin % has ranged from 4.08 to 21.18 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Diagnostics & Research company?
A good Operating Margin % depends on the Medical Diagnostics & Research industry context. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Sai Life Sciences and its competitors. Sai Life Sciences's current Operating Margin % is 21.80%, which is 75% above median its own 10-year median of 12.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sai Life Sciences stock overvalued right now?
Sai Life Sciences (NSE:SAILIFE) has a current Operating Margin % of 21.80%. The current Operating Margin % is 21.80%, which is 75% above median its 10-year median of 12.44. Sai Life Sciences' overall GF Score™ is 18/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Sai Life Sciences (NSE:SAILIFE), the current Operating Margin % is 21.80% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sai Life Sciences Business Description

Other Exchanges 544306:India
Address Gachibowli Miyapur Road, L4- 01 & 02, SLN Terminus Survey, Survey no. 133, Gachibowli, Hyderabad, TG, IND, 500032
Sai Life Sciences Ltd is an innovator-focused, contract research, development, and manufacturing organization. It provides end-to-end services across the drug discovery, development, and manufacturing value chain, for small molecule new chemical entities (NCE), to pharmaceutical innovator companies and biotechnology firms. It possesses both; discovery/contract research (CRO) and chemistry, manufacturing, and control (CMC)/contract development and manufacturing organization (CDMO) capabilities. The company has only one reportable segment: contract research, development, and manufacturing. Geographically it operates in India as well as Outside India.
18GF Score

Get the complete analysis for NSE:SAILIFE

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,221.30
Price